Recombinant attenuated Salmonella harboring 4-1BB ligand gene enhances cellular immunity (Q28573483)

31 January 2017

title

Recombinant attenuated Salmonella harboring 4-1BB ligand gene enhances cellular immunity (English)

1 reference

31 January 2017

Jian-Xin Ye

1

1 reference

31 January 2017

Yuan-Ting Zhang

2

1 reference

31 January 2017

Xue-Guang Zhang

3

1 reference

31 January 2017

Da-Ming Ren

4

1 reference

31 January 2017

Wei-Chang Chen

5

1 reference

31 January 2017

language of work or name

English

0 references

publication date

10 March 2009

1 reference

31 January 2017

1 reference

31 January 2017

volume

27

1 reference

31 January 2017

issue

11

1 reference

31 January 2017

page(s)

1717–1723

1 reference

T cell co-stimulatory molecules other than CD28.

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.031

Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.031

Targeted and untargeted CD137L fusion proteins for the immunotherapy of experimental solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.031

4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.031

Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.031

Oral somatic transgene vaccination using attenuated S. typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.031

Live attenuated Salmonella: a paradigm of mucosal vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.031

Cancer immunotherapy based on killing of Salmonella-infected tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.031

Antibiotic-free plasmid stabilization by operator-repressor titration for vaccine delivery by using live Salmonella enterica Serovar typhimurium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.031

Recombinant vaccines based on translocated effector proteins of Salmonella Pathogenicity Island 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.031

Synergistic antitumor efficacy of suicide/ePNP gene and 6-methylpurine 2'-deoxyriboside via Salmonella against murine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.031

Suicide gene/prodrug therapy using salmonella-mediated delivery of Escherichia coli purine nucleoside phosphorylase gene and 6-methoxypurine 2'-deoxyriboside in murine mammary carcinoma 4T1 model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.031

Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.031

4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.031

10.1016/J.VACCINE.2009.01.031

7 January 2021

Identifiers

DOI

1 reference

31 January 2017

1 reference